Glecaprevir and Pibrentasvir

Mavyret

Hepatitis C Virus NS3/4A Protease Inhibitor

NADAC/unit $152.8570

No Shortage Tier 1: 29.8% PA Req: 155.3%

vs. brand Mavyret: Generic saves up to -1429% per unit

Covered Lives

Generic Manufacturers

ABBVIE INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Glecaprevir and Pibrentasvir drfinder.aiFind doctors who prescribe Glecaprevir and Pibrentasvir rxnews.aiLatest news about Glecaprevir and Pibrentasvir

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.